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Abstract 
Macromolecular nuclear import is an energy and signal-dependent process. The best 
characterised type of nuclear import consists of proteins carrying the classical NLS that is 
mediated by the heterodimeric receptor importin α/β Spliceosomal snRNPs U1, U2, U4 
and U5 nuclear import depend both on the 5’ terminal m3G (trimethylguanosine) cap 
structure of the U snRNA and the Sm core domain. Snurportin 1 recognises the m3G-cap 
structure of m3G-capped U snRNPs. In this report, we show how a synthesised 
trimethylguanosine nucleoside affects the binding of Snurportin 1 to m3G-capped U1 
snRNA in a UV-cross-linking assay.  The data indicated that TMG nucleoside is an 
essential component required in the recognition by Snurportin 1; thus, suggesting that 
interaction of Snurportin 1 with U1 snRNA is not strictly dependent on the presence of 
whole cap structure, but rather on the presence of TMG nucleoside structure. These 
results indicate that the free nucleoside TMG could be a candidate to be an inhibitor of 
the interaction between Snurportin and U snRNAs. We also show the behaviour of free 
TMG nucleoside in in vitro U snRNPs nuclear import 
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INTRODUCTION 
 
The selective transport of proteins and ribonucleoproteins between the nucleus and the 
cytoplasm of eukaryotic cells is an important activity that integrates the functions of 
protein synthesis, RNA genesis and DNA replication. Both protein and nucleoprotein 
complexes are actively transported through the nuclear pore complex (NPC), embedded 
in the nuclear envelope, a process characterised by energy and signal dependence, thus 
indicating that it is mediated by carriers (reviewed in Gorlich and Mattaj (1)) . 
 
A major breakthrough in the study of nuclear import was the development of effective in 
vitro systems (2). Macromolecular import has been well established for proteins that 
carry a short basic nuclear localisation signal (NLS). In a first step, the NLS is recognised 
by a soluble heterodimeric receptor known as the importin α/β  heterodimer. The importin 
α subunit (60 kDa) functions as an anchor, termed as adapter between NLS peptide and 
importin β: importin α binds to the NLS protein; at the same time importin α binds to the 
IBB domain of importin β (97 kDa). The NLS-receptor complex is then targeted to the 
NPC via importin β This complex is subsequently translocated through the NPC, by an 
energy-dependent mechanism, with the help of Ran-GTPase and NTF2.  
 
A second class of NLS is the M9 domain, which is present in a heterogeneous-nuclear 
hnRNP A1. The M9 domain is enriched in glycine and aromatic residues and can bind 
directly to its receptor transportin, thus, in this protein import pathway there is no 
requirement of an adapter (importin α-like) for the binding (3). Other import signals, like 
the classical NLS, have been identified. They are composed mainly of basic amino acids 
and were found in ribosome proteins and histone H1 (4; 5). In addition, the U1A and 
U2B” import does not follow the NLS model and requires a new mediator of nuclear 
protein import (6). 
 
A third class of import signal was identified in U snRNPs (U small nuclear 
ribonucleoproteins). The U snRNPs are essential components of the splicing machinery 
assembled in a complex sequence of events in both the nuclear and the cytoplasmic 
compartments (see reviews in Will and Luhrmann (7; 8)). The trimethylguanosine (m3G) 
cap is the hallmark of the U snRNAs (U small nuclear RNAs family) (9). Major U 
snRNPs U1, U2, U4/U6.U5 are essential spliceosomal factors and they are complexes of 
U snRNAs and a very characteristic set of common and specific polypeptides (10). The 
common polypeptides (B’, B, D1, D2, D3, E, F and G) form a common structure present 
in all the spliceosomal U snRNPs, the so-called Sm core. This event requires the survival 
of motor neuron (SMN) protein complex’s activity (8;11-13). With the sole exception of 
U6 snRNA, which is capped with MeGTP (14), all the major U snRNAs contain the m3G 
cap in human cells. Shortly after polymerase II transcription, UsnRNAs are capped with a 
7-methylguanosine (m7G) structure (15). The newly transcribed UsnRNAs are exported 
to the cytoplasm by binding to an adaptor protein called PHAX (16). The stable 
formation of Sm core in the cytoplasm promotes the hypermethylation of the m7G cap to 
a 2,2,7-trimethylguanosine-cap (m3G) (17). Both the Sm binding site domain and the 
m3G cap constitute the bipartite nuclear localization signal that targets the U snRNPs to 
the nucleus (18;19).  
 
Snurportin 1, a 45 kDa protein, mediates nuclear import of m3G-capped uridine-rich 
small nuclear RNPs  (U snRNPs) (20). Snurportin is thus an adaptor that recognises the 
m3G-cap structure and links UsnRNPs to importin β for subsequent transport to the 
nucleus (20;21). Once in the nucleus, Snurportin 1 returns to the cytoplasm after each 
round of import. The re-export of Snurportin 1 is mediated by CRM1 (22). The import of 
U snRNPs does not need importin α (23). Furthermore, the depletion of importin α 
stimulates the nuclear import of U snRNPs, indicating competition between U snRNP 
nuclear import factors and importin α (23) 
 
Previously, our group has synthesised high amounts of non-commercial TMG 
(trimethylguanosine) nucleoside (24) by using a modified synthetic procedure described 
for nucleosides conjugates (25). Moreover, we showed that the synthesised TMG product 
is immunologically identical to the m3G cap of the UsnRNPs. These experiments used 
antibodies raised against TMG-KLH conjugates. Anti-TMG antibodies precipitated the U 
snRNAs and this pull-down could be competed with free TMG (24). Here, we show how 
TMG nucleoside affects the binding of Snurportin to m3G-capped U1 snRNA in a new  
UV-cross-linking assay created based on previous procedures (20;26). We next attempted 
to test the effect caused by the addition of TMG nucleoside in an in vitro UsnRNPs 
import using Hela digitonin permeabilised cells. Surprisingly, TMG not only did not 
block U snRNPs import, but in fact stimulated it, when added in concentrations lower 
than 0.5 mM. When 1 and 2 mM of free TMG were added, no U snRNPs import 
stimulation was observed. We discuss the aspects involved in the behaviour of free TMG 
in nuclear import and cross-linking assays. 
 
RESULTS AND DISCUSSION 
 
Snuportin1 binds only to m3G cap in the new cross-linking assay 
 
The purified his-tagged Snurportin 1 has an apparent molecular weight of 47 kDa (Fig. 1, 
lane 1) in 15% SDS-PAGE gel. In this gel, we could observe that Snurportin 1 has been 
well expressed and purified through nickel-NTA agarose and was suitable for using in 
further experiments. We have created a new UV-cross-linking assay based on previous 
publications (20;26) and tested its efficiency in the binding of Snurportin 1 to m7G and 
m3G caps. U1 snRNA was transcribed using radioactive label and capped with m7G and 
m3G nucleotides and was then mixed with recombinant Snurportin 1. 
 
After UV irradiation and RNAse 1 treatment, the samples were subjected to SDS-PAGE 
and the protein was visualised by autoradiography. Snurportin 1 clearly bound to the m3G 
cap as indicated by the signal observed (Fig. 2, lane 2); however, Snurportin 1 did not 
bind to m7G cap (Fig. 2, lane 1). Thereby, indicating the efficiency of our optimised 
assay. Furthermore, we tested whether the nucleoside synthesised here, i.e. the TMG 
nucleoside, is able to compete with the binding of Snurportin 1 to the m3GpppG-capped 
U1 snRNA, as free m3GpppG cap does. 
 
Trimethylguanosine nucleoside (TMG) inhibits cross-linking between Snurportin 1 
and m3G-capped U1 snRNA 
 
Free m3GpppG cap can compete with the binding of Snurportin 1 to m3GpppG-capped 
U1 snRNA. In Fig 3A,B, we observe the competition with 1.0 (Fig 3A, lane 2), 0.1 (Fig 
3B, lane 2) and 0.01 mM (Fig 3B, lane 3) of m3GpppG cap. By comparing the 
disappearance of Snurportin 1 cross-linked bands (3A, lane 2; 3B lane 2) with the cross-
linked snurportin band (3A and B, lane 1) we could conclude that 1 and 0.1 mM 
m3GpppG cap produced a total inhibition of binding. These data verify that the binding of 
Snurportin 1 to m3GpppG cap, in the cross-linking assay as created here, has the same 
specificity of m3G cap oligo (m3GpppAmpUmpA) observed previously (20). TMG was 
synthesised from m2,2G (27) by methylation of position 7 of the ring with dimethyl 
sulphate (24). Surprisingly, free TMG nucleoside was also able to inhibit the binding 
between Snurportin 1 and m3G cap in UV-cross-linking assays when used in 1 and 0.1 
mM as competitor (Fig 3, lanes 4 and 5), although it could be anticipated from the crystal 
structure of 2,2,7-trimethyl-GpppG bound to snurportin 1 (cap-binding fragment) 
published very recently (28). In the present assay, only in the presence of 1 mM TMG a 
total inhibition of binding was obtained. In fact, TMG nucleoside has a decreased 
strength of interaction with snurportin 1 of approximately one order of magnitude. 
 
This effect may be due to the presence of whole nucleotide structure of m3GpppG. We 
also observed that m2,2G (2,2-dimethylguanosine) nucleoside was unable to inhibit the 
UV-cross-linking between Snurportin 1 and m3GpppG-capped U1 snRNA (not shown), 
confirming that methylation in position 7 of the guanosine ring is essential in this respect 
(20;24). Therefore, these data strongly indicate that TMG nucleoside is an essential 
component required in the recognition by Snurportin 1; thus, suggesting that interaction 
of Snurportin 1 with U1 snRNA is not strictly dependent on the presence of whole cap 
structure, but rather on the presence of TMG nucleoside structure. However, whether 
artificial constructs made with TMG nucleoside can exhibit the same binding avidity with 
native Snurportin 1 is still an open question. Moreover, the next step will be to 
characterise the binding properties of TMG nucleoside in in vitro nuclear import assays. 
 
U snRNP import is stimulated by trimethylguanosine nucleoside (TMG) in 
concentrations under 0.5 mM. 
 
It is known that U snRNP import is effectively blocked by trimethylguanosine (m3G) cap 
analog m2,2,7GTP but it is not affected by the monomethylguanosine cap analog m7GTP 
(23). Both effects may be seen in Figure 4 B and C-D, respectively. The nuclear 
fluorescence seen in Fig 4A, due to nuclear import of fluorescent U snRNPs, has 
decreased in B, by adding cap m3GpppG. On the other hand, the panels C and D shows 
that nuclear fluorescence is the same of control A, thus demonstrating that the adding of 
m7GpppG cap has not affected the import rate of fluorescent U snRNPs into the nucleus. 
 
In this direction we tested if our compound, the free TMG, could alter an in vitro U 
snRNPs import. So, we verified that at concentrations higher than 0.5 mM there is U 
snRNP import inhibition, mimicking the effect observed in the presence of m3GpppG cap 
analog, but surprisingly, under this concentration we observed a stimulation of U snRNPs 
import.  
 
Figure 4 also shows an U snRNPs in vitro import assay in the presence of free TMG. 
Surprisingly, TMG not only did not block U snRNPs import, but in fact stimulated it 
(Figure 4 compare F with control E) when used with the molarity of 0.5 mM. 
Nevertheless, when 1 and 2 mM of free TMG were added (Figure 4, G and H, 
respectively) no U snRNPs import stimulation was observed. In conclusion, when TMG 
is added in low concentrations (under 0.5 mM, not shown), it may stimulates U snRNPs 
nuclear import. These experiments have been repeated several times, including various 
TMG concentrations till 0.5 mM, and both the stimulation and inhibitory effects observed 
were the same. 
 
U snRNP import is blocked by trimethylguanosine nucleoside (TMG) in 
concentrations of  1  mM. 
 
A fluorescent BSA conjugated with a peptide containing the reverse NLS sequence 
(“SLN”) was also used to check the veracity of the effect caused by free TMG in a U 
snRNPs nuclear import assay. As the SLN signal is not recognised by the protein import 
pathway, it was used to discard the possibility of a passive diffusion of the conjugated. 
When TMG is used at a final concentration of 2 mM it seems to be toxic to the cells as 
shown when it was assayed with BSA-SLN, leading to a passive diffusion of fluorescent 
conjugate into the nucleus (Fig 5, D). This effect was monitored by fluorescence in the 
nucleus (Fig 5, D compared with the control A). BSA-SLN in in vitro import assays 
either alone (Fig 5 A) or with the addition of 1 mM (Fig 5, panel C) or 0.5 mM (Fig 5, 
panel B) of TMG nucleoside did not lead to increased nuclear fluorescence. A slight 
fluorescence can bee seen around the nuclear membrane. These experiments confirm that 
both the stimulation of import of U snRNPs in the presence of 0.5 mM TMG free 
nucleoside, and the blocking of UsnRNPs import in the presence of 1 mM TMG is due to 
an active import of the karyophile. 
 
TMG has an unstable imidazole ring, which is a property of this product, and the 
imidazole degradation does not depend on the product’s synthesis procedure. The 
degradation of the imidazole ring is due to two different reactions: depurination, a 
reaction catalyzed by acids; and the opening of the imidazole ring, by susceptibility to 
nucleophilic attack in basic pH. Both reactions are favored by the methylation at position 
7.  Some amount of the products obtained from the imidazole degradation may be present 
in our preparations; they could be toxic to the nuclear membrane and the stimulation 
effect could be simply due to a passive diffusion through broken nuclear membranes. The 
results observed in the presence of 2 mM TMG indicate that the imidazole degradation is 
affecting the nuclear membrane, thus leading to a passive nuclear diffusion of BSA-SLN. 
Nevertheless, the results observed in the presence of 0.5 and 1 mM TMG compared with 
the negative control BSA-SLN indicated that the minor imidazole degradation products 
was not affecting the membrane at the concentration range, thus BSA-SLN is not 
obtained in the nucleus by passive diffusion in presence of several concentrations of 
TMG nucleoside. The inhibition effect indicates that TMG at concentrations higher than 
0.5 mM really mimics the U snRNPs cap and inhibits the active transport. The 
stimulation effect under 0.5 mM is so far not easily explained; we can suggest that TMG 
would have some effect on the molecular attraction and concentration of other factors, 
including those involved in import, a role already suggested for other protein-protein 
interaction systems (29-33). 
 
 Future experiments will undoubtedly help to elucidate the roles of TMG nucleoside in 
the molecular mechanisms behind these processes. 
 
Materials and Methods 
The m7G-cap analogue was purchased from Biolabs. m3GpppG was synthesised as 
described elsewhere (34;35), Radio-labelled nucleotide triphosphates were obtained from 
Amersham. The RNAse inhibitor was obtained from Gibco and the SP6 polymerase used 
for the pHU1 transcription was from Boehringer. Recombinant Snurportin 1 was a kind 
gift from Dr Martin Hetzer. All nuclear import procedures can also be found in Dingwall 
and Palacios (36). 
 
Recombinat Snurportin expression and purification 
Snurportin 1 was cloned into the BamHI-XmaI sites of pQE30 (Qiagen), expressed with 
an NH2-terminal His tag and purified on nickel-NTA agarose followed by dialysis in 20 
mM Hepes-KOH, pH 7.5, 200 mM NaCl, 2 mM magnesium acetate, 250 mM sucrose.  
 
TMG nucleoside synthesis 
TMG nucleoside synthesis was performed as follows: the TMG nucleoside precursor was 
m2,2G, which was synthesised as described previously (27). The synthesis of TMG 
nucleoside used in the cross-linking assays was performed essentially as described 
previously (24). 
 
UV-cross-linking assay 
The following technique was created based on previous citations (1;22). pHU1A (37) was 
transcribed with m3G and m7G caps in a transcription assay where α32UTP (and no cold 
UTP) was used. The transcripts were purified through centri spin 10 (Princenton) 
columns equilibrated with Roeder 200 mM KCl (10 mM HEPES pH 7.9; 1.5 mM MgCl2; 
200 mM KCl; 500 mM DTT; 500 mM PMSF; 5% glycerol) buffer. To visualise the 
binding between Snurportin 1 and m3G by UV-cross-linking, 1 pmol of newly transcribed 
m3GpppG-capped U1 snRNA (250-350 × 104 counts per min) was incubated for 15 min 
on ice with 1.5 µg of recombinant Snurportin 1 in a total volume of 10 µl. Reaction 
mixtures were irradiated at 254 nm with a Sylvania G8T5 germicidal UV lamp for 5 min 
at a distance of 2 cm, and then placed on ice for 2 min. To each reaction, 1 µl RNAse A 
(3 mg/ml) was added and the samples were incubated for 30 min at 37ºC. In competition 
assays, recombinant Snurportin 1 was mixed with 0.1 and 1 mM m3G cap or TMG 
nucleoside on ice for 30 min prior to UV-irradiation. Cross-linked proteins were 
separated on 12.5 or 15% SDS-PAGE gels and visualised by autoradiography (Film 
KODAK BioMax MS in an intensify Kodak Biomax MS screen). 
 
Preparation of fluorescent karyophiles 
 U snRNPs were purified from HeLa nuclear extracts by using an immunoaffinity column 
anti-trimethylguanosine (anti-m3G) as described by (38). U snRNPs were concentrated to 
1 mg/ml with Filtron 30K (Pall Filtron). In the last step of concentration U snRNPs were 
resuspended in 100 mM borate buffer, pH 7.5. FLUOS (Boehringer) was prepared fresh 
in DMSO (dimethylsulfoxid) and added to U snRNPs in 100-fold molar excess. The 
reaction proceeded for 45 min at room temperature with rotation in the darkness, and was 
stopped by adding Tris to 10 mM, pH 7.5. The labeled U snRNPs were separated from 
the free dye by loading the sample in a Bioget p60 column previously equilibrated with 1 
X transport buffer-TB-(20 mM Hepes-KOH, pH 7.3; 110 mM KOAc; 5 mM NaAc; 2 
mM MgAc; 1.0 mM EGTA; 1 mM DTT; 0.1 mM PMSF; 1 µg/ml aprotinin; 1 µg/ml 
pepstatin A, 1 µg/ml leupeptin, 5% v/v sucrose). Fluorescent U snRNPs were repurified 
again in an anti-m3G column and eluted using 15 mM 7-methylguanosine in TB. 
 
BSA was cross-linked to a non-functional peptide with the reverse NLS sequence (SLN) 
(15-20 peptides per molecule), as described for BSA-NLS (39). Conjugation to the carrier 
protein was obtained through the N-terminal cysteine residue and the glycine residues 
serve as a flexible hinge or spacer to separate the peptide from the protein itself. BSA-
NLS conjugate was also labelled with FLUOS following the manufacturer’s instructions.  
 
 Preparation of permeabilised cells 
The cells were cultivated in a Dulbecco’s modified Eagles’s medium (Gibco), 
supplemented with 10% fetal calf serum and penicillin/streptomycin (Gibco-BRL) at 
370C, 5% CO2, and transferred to 10 plastic flasks (125 m2). They were grown to 
approximately 70% confluence and harvested using 5 ml of a non-enzymatic cell 
dissociation solution (Sigma) for 10 min at 37ºC. The cells were detached from the walls 
and then transferred to a 50 ml Falcon tube. The subsequent steps were carried out on ice. 
The cells were washed 3 times with ice-cold permeabilisation buffer-PB (50 mM 
HEPES-KOH, pH 7.3; 50 mM KOAc; 8 mM MgCl2; 2 mM EGTA) and resuspended to a 
cell density of 1-5 X 106 cell/ml in ice-cold PB. Digitonin (Fluka) was then added to 50 
µg/ml and the cells were left on ice for exactly 5 min. Afterwards, the cells were washed 
three times with PB and finally resuspended at a density of 5-10 X 106 cell/ml in TB that 
contained 5% DMSO. The cells were then aliquoted into cold eppendorf tubes and the 
tubes were frozen slowly in a Styrofoam box for 1 hr at -20ºC and then stored at -80ºC. 
 
Nuclear import in vitro assay 
 
Both U snRNPs and BSA-SLN in vitro import reactions have always contained 1 µl of a 
5 mg/ml nucleoplasmin core (NPc), obtained as described elsewhere (40), 1 µl of a 10 X 
energy-regenerating system (the final concentration in the assay must be 0.5 mM ATP, 
0.5 mM GTP, 10 mM creatine phosphate, 50 µg/ml creatine phosphokinase); 1 µl of 
digitonin-permeabilised cells (1 X 104 cells); TB 1 X (from 5 ml transport buffer plus 5 
µl DTT 1 M; 50 µl Trasylol 500000 KIE Bayer; 5 µl pepstatin 1 mg/ml; 5 µl PMSF 1 M; 
1 µl leupeptin 5 mg/ml; 250 mM sucrose) with or without the factors to be tested. All the 
purified TMG-binding proteins fractions were previously desalted through micro bio-spin 
chromatography columns (BioRad bio-gel P-6) in order to change the buffer to TB and 
remove free TMG nucleoside. 
 
BSA-SLN import was performed in a final volume of 10 µl always containing 2 µl of 
Xenopus egg extract (41) previously spun at 13.000 rpm for 10 min- and 1 µl of a 1/10 
dilution of BSA-SLN  in TB (at a final concentration of 70 µg/ml). First, the BSA-SLN 
was premixed with the Xenopus extract and the factors and incubated on ice for 5 min. 
Then, a mixture was prepared with the cells and the NPc and then added to the first 
premix. To start the import reaction the energy mix was added and the reaction proceeded 
for 10 min, at room temperature. For U snRNPs import, each reaction was performed in 
15-17 µl and also contained 6 µl of importin α-depleted Xenopus extract (described 
below), 0.5 µl of tRNA (to a final concentration of 0.2 mg/ml), and 5 µl of fluorescent U 
snRNPs (to a final concentration of 20 µg/ml). Initially, U snRNPs were premixed with 
Xenopus extract and then the factors, and the mixture were left on ice for 15 min. Then a 
mixture was prepared with tRNA, NPc and digitonin-permeabilised cells which was 
added to the eppendorfs containing the first premix. In order to start the reaction, the 
energy mix was added and the reaction was proceeded for 60-90 min at room temperature, 
in the dark. When free nucleotides and TMG nucleoside were added to the assay they 
were mixed with U snRNPs and Xenopus extract before leaving the mixture on ice. 
 
Both reactions were stopped by fixing with 200 µl of 8 % (w/v) paraformaldehyde on ice 
together with 200 µl DAPI dye (330 ng/µl) in TB. The fixed reaction was layered over 
700 µl of 30 % sucrose in a tube containing a poly(lysine)-coated cover slip (MW 
30,000-70,000) at 1 mg/ml in water. After centrifugation (3.000 rpm, 15 min.) the cover 
slip was recovered, washed with PBS and mounted on top of a drop of Vectashield 
mounting medium (Vector Laboratories, Burlingame CA) and viewed directly. Images 
acquisition and the quantification of nuclear fluorescence were performed as described 
(36;39). 
  
Xenopus extracts  
The Xenopus extract  (41) used in U snRNPs import was importin α depleted by passing 
through an immunoaffinity column with an antibody against an N-terminal peptide from 
Xenopus importin α as described (23). 
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 FIGURES 
 
 
 
Fig 1. Expression and purification of recombinant Snurportin 1. Snurportin 1 was 
expressed in pQE30 (Qiagen) as his-tagged recombinant protein and purified through 
nickel-NTA agarose. Snurportin 1 was submmited to 15% SDS-PAGE gel in order to 
check its integrity and purity. 5 µg of purified recombinant Snurportin 1 (Lane 1); protein 
molecular weight markers (Lane 2). The numbers on the right indicate the molecular 
weights in kDa. The gel was stained with Coomasie. 
 
 
  
 
 
Fig 2. UV cross-linking assay. U1 snRNA was transcribed with both m7GpppG and 
m3GpppG caps in an assay with only 32UTP (no cold UTP). To the cross-linking assay, 
1.5 µg of Snurportin 1 was incubated with radio-labelled U1 snRNAs on ice in a total 
volume of 10 µl for 15 min. Both mixtures were irradiated with 254 nm UV Sylvania 
G8T5 for 5 min at a distance of 2 cm. The cross-linked Snurportin 1 was analysed on a 
15% SDS-PAGE gel. Snurportin 1 cross-linked to m7GpppG-U1 snRNA (Lane 1) and to 
m3GpppG-U1 snRNA (Lane 2). 
 
  
 
Fig.3. Snurportin1 binding to m3GpppG cap is inhibited in the presence of free TMG 
nucleoside. U1 snRNA was transcribed with m3GpppG cap, in an assay without UTP 
cold. To the cross-linking assay, 1.5 µg of Snurportin 1 was incubated with radio-labelled 
U1 snRNAs on ice in a total volume of 10 µl for 15 min. Both mixtures were irradiated 
with 254 nm UV Sylvania G8T5 for 5 min at a distance of 2 cm. In competition assays, 
Snurportin1 was mixed for 30 min on ice with either m3GpppG cap or free TMG 
nucleoside prior to UV irradiation. The cross-linked Snurportin 1 was analysed on a 12% 
SDS-PAGE gel. Fig 3A. Snurportin 1 cross-linked to m3GpppG-U1snRNA (Lane 1, see 
arrow) competed with 1 mM m3GpppG cap (Lane 2). Fig 3B. Snurportin 1 cross-linked 
to m3GpppG-U1snRNA (Lane 1) competed with 0.1 (Lane 2) and 0.01 (Lane 3) mM 
m3GpppG cap, or with 1 (Lane 4) and 0.1 (Lane 5) mM TMG nucleoside.  
 
 
  
 
Figure 4. U snRNPs import in vitro assay in the presence of TMG nucleoside. Digitonin-
permeabilised HeLa cells were incubated with purified and fluorescently labelled U 
snRNPs for 90 min, at room temperature, in the presence of Xenopus egg extracts 
importin α depleted, nucleoplasmin core (NPc), GTP, ATP and an ATP regeneration 
system (see Material and Methods). A and E) U snRNPs import reaction control in the 
absence of free nucleosides or nucleotides; B) U snRNPs import in the presence of 2 mM 
m3GpppG cap; C-D) U snRNPs import in the presence of 2 mM m7GpppG; F-H) U 
snRNPs import in the presence of 0.5, 1 and 2 mM of TMG nucleoside, respectively.  
Magnification bars represent 20 micrometers. ABCD and EFGH represent different 
assays. 
 
  
 
Figure 5. BSA-SLN import in vitro assay in the presence of TMG nucleoside. Digitonin-
permeabilised HeLa cells were incubated with fluorescently labelled BSA-SLN for 10 
min, at room temperature, in the presence of Xenopus egg extracts, nucleoplasmin core 
(NPc), GTP, ATP and an ATP regeneration system (see Material and Methods). A) BSA-
SLN  import in the absence of TMG (control); B-D) BSA-SLN Import in the presence 0.5, 
1 and 2 mM of free TMG, respectively. Magnifications bars for A and B represent 10 
micrometers, for C and D, 20 micrometers. 
 
